Stay updated on Satralizumab in Thyroid Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.

Latest updates to the Satralizumab in Thyroid Eye Disease Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision tag Revision: v3.5.4 was added to the page footer, replacing the previous Revision: v3.5.3. This reflects a backend or UI update tag without altering the study content or user interactions.SummaryDifference0.0%

- Check21 days agoChange DetectedThe study title on the page has been updated to the official 'Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease (SatraGO-1)'. The changes also reflect updates to the study's record history with new dates and removal of prior dates, indicating the latest version of the trial record.SummaryDifference0.2%

- Check29 days agoChange DetectedThe revision tag on the page was updated from v3.5.2 to v3.5.3, signaling a minor update to the page’s documentation. This change does not modify the main content or functionality.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing Revision: v3.5.0. This appears to be an internal version update with no visible changes to study information.SummaryDifference0.0%

- Check65 days agoChange Detected- Italy location entry updated from Napoli, Campania, Italy, 80131 to Naples, Campania, Italy, 80131.SummaryDifference0.0%

- Check72 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Satralizumab in Thyroid Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.